[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

United States Reverse Transcriptase Market Report 2017

October 2017 | 105 pages | ID: U169D537E14EN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the United States Reverse Transcriptase market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
  • The West
  • Southwest
  • The Middle Atlantic
  • New England
  • The South
  • The Midwest
  • with sales (volume), revenue (value), market share and growth rate of Reverse Transcriptase in these regions, from 2012 to 2022 (forecast).
United States Reverse Transcriptase market competition by top manufacturers/players, with Reverse Transcriptase sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Thermo Fisher
  • Promega
  • Roche
  • Agilent
  • Takara Bio
  • Qiagen
  • Bio-Rad
  • Fapon Biotech
  • Toyobo
  • Vazyme
  • New England Biolabs
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • MMLV Reverse Transcriptase
  • AMV Reverse Transcriptase
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Reverse Transcriptase for each application, including
  • PCR
  • Sequencing
  • Cloning
If you have any special requirements, please let us know and we will offer you the report as you want.
United States Reverse Transcriptase Market Report 2017

1 REVERSE TRANSCRIPTASE OVERVIEW

1.1 Product Overview and Scope of Reverse Transcriptase
1.2 Classification of Reverse Transcriptase by Product Category
  1.2.1 United States Reverse Transcriptase Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Reverse Transcriptase Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 MMLV Reverse Transcriptase
  1.2.4 AMV Reverse Transcriptase
1.3 United States Reverse Transcriptase Market by Application/End Users
  1.3.1 United States Reverse Transcriptase Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 PCR
  1.3.3 Sequencing
  1.3.4 Cloning
1.4 United States Reverse Transcriptase Market by Region
  1.4.1 United States Reverse Transcriptase Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Reverse Transcriptase Status and Prospect (2012-2022)
  1.4.3 Southwest Reverse Transcriptase Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Reverse Transcriptase Status and Prospect (2012-2022)
  1.4.5 New England Reverse Transcriptase Status and Prospect (2012-2022)
  1.4.6 The South Reverse Transcriptase Status and Prospect (2012-2022)
  1.4.7 The Midwest Reverse Transcriptase Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Reverse Transcriptase (2012-2022)
  1.5.1 United States Reverse Transcriptase Sales and Growth Rate (2012-2022)
  1.5.2 United States Reverse Transcriptase Revenue and Growth Rate (2012-2022)

2 UNITED STATES REVERSE TRANSCRIPTASE MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Reverse Transcriptase Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Reverse Transcriptase Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Reverse Transcriptase Average Price by Players/Suppliers (2012-2017)
2.4 United States Reverse Transcriptase Market Competitive Situation and Trends
  2.4.1 United States Reverse Transcriptase Market Concentration Rate
  2.4.2 United States Reverse Transcriptase Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Reverse Transcriptase Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES REVERSE TRANSCRIPTASE SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Reverse Transcriptase Sales and Market Share by Region (2012-2017)
3.2 United States Reverse Transcriptase Revenue and Market Share by Region (2012-2017)
3.3 United States Reverse Transcriptase Price by Region (2012-2017)

4 UNITED STATES REVERSE TRANSCRIPTASE SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Reverse Transcriptase Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Reverse Transcriptase Revenue and Market Share by Type (2012-2017)
4.3 United States Reverse Transcriptase Price by Type (2012-2017)
4.4 United States Reverse Transcriptase Sales Growth Rate by Type (2012-2017)

5 UNITED STATES REVERSE TRANSCRIPTASE SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Reverse Transcriptase Sales and Market Share by Application (2012-2017)
5.2 United States Reverse Transcriptase Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES REVERSE TRANSCRIPTASE PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Thermo Fisher
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Reverse Transcriptase Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Thermo Fisher Reverse Transcriptase Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Promega
  6.2.2 Reverse Transcriptase Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Promega Reverse Transcriptase Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Roche
  6.3.2 Reverse Transcriptase Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Roche Reverse Transcriptase Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Agilent
  6.4.2 Reverse Transcriptase Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Agilent Reverse Transcriptase Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Takara Bio
  6.5.2 Reverse Transcriptase Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Takara Bio Reverse Transcriptase Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Qiagen
  6.6.2 Reverse Transcriptase Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Qiagen Reverse Transcriptase Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Bio-Rad
  6.7.2 Reverse Transcriptase Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Bio-Rad Reverse Transcriptase Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Fapon Biotech
  6.8.2 Reverse Transcriptase Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Fapon Biotech Reverse Transcriptase Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Toyobo
  6.9.2 Reverse Transcriptase Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Toyobo Reverse Transcriptase Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Vazyme
  6.10.2 Reverse Transcriptase Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Vazyme Reverse Transcriptase Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 New England Biolabs

7 REVERSE TRANSCRIPTASE MANUFACTURING COST ANALYSIS

7.1 Reverse Transcriptase Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Reverse Transcriptase

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Reverse Transcriptase Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Reverse Transcriptase Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES REVERSE TRANSCRIPTASE MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Reverse Transcriptase Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Reverse Transcriptase Sales Volume Forecast by Type (2017-2022)
11.3 United States Reverse Transcriptase Sales Volume Forecast by Application (2017-2022)
11.4 United States Reverse Transcriptase Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Product Picture of Reverse Transcriptase
Figure United States Reverse Transcriptase Market Size (K Pcs) by Type (2012-2022)
Figure United States Reverse Transcriptase Sales Volume Market Share by Type (Product Category) in 2016
Figure MMLV Reverse Transcriptase Product Picture
Figure AMV Reverse Transcriptase Product Picture
Figure United States Reverse Transcriptase Market Size (K Pcs) by Application (2012-2022)
Figure United States Sales Market Share of Reverse Transcriptase by Application in 2016
Figure PCR Examples
Table Key Downstream Customer in PCR
Figure Sequencing Examples
Table Key Downstream Customer in Sequencing
Figure Cloning Examples
Table Key Downstream Customer in Cloning
Figure United States Reverse Transcriptase Market Size (Million USD) by Region (2012-2022)
Figure The West Reverse Transcriptase Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Reverse Transcriptase Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Reverse Transcriptase Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Reverse Transcriptase Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Reverse Transcriptase Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Reverse Transcriptase Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Reverse Transcriptase Sales (K Pcs) and Growth Rate (2012-2022)
Figure United States Reverse Transcriptase Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Reverse Transcriptase Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table United States Reverse Transcriptase Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table United States Reverse Transcriptase Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Reverse Transcriptase Sales Share by Players/Suppliers
Figure 2017 United States Reverse Transcriptase Sales Share by Players/Suppliers
Figure United States Reverse Transcriptase Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Reverse Transcriptase Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Reverse Transcriptase Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Reverse Transcriptase Revenue Share by Players/Suppliers
Figure 2017 United States Reverse Transcriptase Revenue Share by Players/Suppliers
Table United States Market Reverse Transcriptase Average Price (USD/Pcs) of Key Players/Suppliers (2012-2017)
Figure United States Market Reverse Transcriptase Average Price (USD/Pcs) of Key Players/Suppliers in 2016
Figure United States Reverse Transcriptase Market Share of Top 3 Players/Suppliers
Figure United States Reverse Transcriptase Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Reverse Transcriptase Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Reverse Transcriptase Product Category
Table United States Reverse Transcriptase Sales (K Pcs) by Region (2012-2017)
Table United States Reverse Transcriptase Sales Share by Region (2012-2017)
Figure United States Reverse Transcriptase Sales Share by Region (2012-2017)
Figure United States Reverse Transcriptase Sales Market Share by Region in 2016
Table United States Reverse Transcriptase Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Reverse Transcriptase Revenue Share by Region (2012-2017)
Figure United States Reverse Transcriptase Revenue Market Share by Region (2012-2017)
Figure United States Reverse Transcriptase Revenue Market Share by Region in 2016
Table United States Reverse Transcriptase Price (USD/Pcs) by Region (2012-2017)
Table United States Reverse Transcriptase Sales (K Pcs) by Type (2012-2017)
Table United States Reverse Transcriptase Sales Share by Type (2012-2017)
Figure United States Reverse Transcriptase Sales Share by Type (2012-2017)
Figure United States Reverse Transcriptase Sales Market Share by Type in 2016
Table United States Reverse Transcriptase Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Reverse Transcriptase Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Reverse Transcriptase by Type (2012-2017)
Figure Revenue Market Share of Reverse Transcriptase by Type in 2016
Table United States Reverse Transcriptase Price (USD/Pcs) by Types (2012-2017)
Figure United States Reverse Transcriptase Sales Growth Rate by Type (2012-2017)
Table United States Reverse Transcriptase Sales (K Pcs) by Application (2012-2017)
Table United States Reverse Transcriptase Sales Market Share by Application (2012-2017)
Figure United States Reverse Transcriptase Sales Market Share by Application (2012-2017)
Figure United States Reverse Transcriptase Sales Market Share by Application in 2016
Table United States Reverse Transcriptase Sales Growth Rate by Application (2012-2017)
Figure United States Reverse Transcriptase Sales Growth Rate by Application (2012-2017)
Table Thermo Fisher Basic Information List
Table Thermo Fisher Reverse Transcriptase Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Thermo Fisher Reverse Transcriptase Sales Growth Rate (2012-2017)
Figure Thermo Fisher Reverse Transcriptase Sales Market Share in United States (2012-2017)
Figure Thermo Fisher Reverse Transcriptase Revenue Market Share in United States (2012-2017)
Table Promega Basic Information List
Table Promega Reverse Transcriptase Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Promega Reverse Transcriptase Sales Growth Rate (2012-2017)
Figure Promega Reverse Transcriptase Sales Market Share in United States (2012-2017)
Figure Promega Reverse Transcriptase Revenue Market Share in United States (2012-2017)
Table Roche Basic Information List
Table Roche Reverse Transcriptase Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Roche Reverse Transcriptase Sales Growth Rate (2012-2017)
Figure Roche Reverse Transcriptase Sales Market Share in United States (2012-2017)
Figure Roche Reverse Transcriptase Revenue Market Share in United States (2012-2017)
Table Agilent Basic Information List
Table Agilent Reverse Transcriptase Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Agilent Reverse Transcriptase Sales Growth Rate (2012-2017)
Figure Agilent Reverse Transcriptase Sales Market Share in United States (2012-2017)
Figure Agilent Reverse Transcriptase Revenue Market Share in United States (2012-2017)
Table Takara Bio Basic Information List
Table Takara Bio Reverse Transcriptase Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Takara Bio Reverse Transcriptase Sales Growth Rate (2012-2017)
Figure Takara Bio Reverse Transcriptase Sales Market Share in United States (2012-2017)
Figure Takara Bio Reverse Transcriptase Revenue Market Share in United States (2012-2017)
Table Qiagen Basic Information List
Table Qiagen Reverse Transcriptase Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Qiagen Reverse Transcriptase Sales Growth Rate (2012-2017)
Figure Qiagen Reverse Transcriptase Sales Market Share in United States (2012-2017)
Figure Qiagen Reverse Transcriptase Revenue Market Share in United States (2012-2017)
Table Bio-Rad Basic Information List
Table Bio-Rad Reverse Transcriptase Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Bio-Rad Reverse Transcriptase Sales Growth Rate (2012-2017)
Figure Bio-Rad Reverse Transcriptase Sales Market Share in United States (2012-2017)
Figure Bio-Rad Reverse Transcriptase Revenue Market Share in United States (2012-2017)
Table Fapon Biotech Basic Information List
Table Fapon Biotech Reverse Transcriptase Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Fapon Biotech Reverse Transcriptase Sales Growth Rate (2012-2017)
Figure Fapon Biotech Reverse Transcriptase Sales Market Share in United States (2012-2017)
Figure Fapon Biotech Reverse Transcriptase Revenue Market Share in United States (2012-2017)
Table Toyobo Basic Information List
Table Toyobo Reverse Transcriptase Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Toyobo Reverse Transcriptase Sales Growth Rate (2012-2017)
Figure Toyobo Reverse Transcriptase Sales Market Share in United States (2012-2017)
Figure Toyobo Reverse Transcriptase Revenue Market Share in United States (2012-2017)
Table Vazyme Basic Information List
Table Vazyme Reverse Transcriptase Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Vazyme Reverse Transcriptase Sales Growth Rate (2012-2017)
Figure Vazyme Reverse Transcriptase Sales Market Share in United States (2012-2017)
Figure Vazyme Reverse Transcriptase Revenue Market Share in United States (2012-2017)
Table New England Biolabs Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Reverse Transcriptase
Figure Manufacturing Process Analysis of Reverse Transcriptase
Figure Reverse Transcriptase Industrial Chain Analysis
Table Raw Materials Sources of Reverse Transcriptase Major Players/Suppliers in 2016
Table Major Buyers of Reverse Transcriptase
Table Distributors/Traders List
Figure United States Reverse Transcriptase Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure United States Reverse Transcriptase Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Reverse Transcriptase Price (USD/Pcs) Trend Forecast (2017-2022)
Table United States Reverse Transcriptase Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Reverse Transcriptase Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Reverse Transcriptase Sales Volume (K Pcs) Forecast by Type in 2022
Table United States Reverse Transcriptase Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Reverse Transcriptase Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Reverse Transcriptase Sales Volume (K Pcs) Forecast by Application in 2022
Table United States Reverse Transcriptase Sales Volume (K Pcs) Forecast by Region (2017-2022)
Table United States Reverse Transcriptase Sales Volume Share Forecast by Region (2017-2022)
Figure United States Reverse Transcriptase Sales Volume Share Forecast by Region (2017-2022)
Figure United States Reverse Transcriptase Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


More Publications